Skip to content

Clinical trials

Phase 3 Polycythemia Vera trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Phase: Phase 3 Country / region: Italy Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20132
20141
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation2
AOP Orphan Pharmaceuticals AG1
CTI BioPharma1
Consorzio Mario Negri Sud1
European Organisation for Research and Treatment of Cancer - EORTC1
Italfarmaco1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Protagonist Therapeutics, Inc.1
Ronald Hoffman1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera11
Thrombocythemia, Essential4
Primary Myelofibrosis3
Bone Marrow Diseases2
Hematologic Diseases2
Myeloproliferative Disorders2
Anemia1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.